Page last updated: 2024-09-04

atazanavir sulfate and Jaundice

atazanavir sulfate has been researched along with Jaundice in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (37.50)	29.6817
2010's	5 (62.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, P; Chirwa, S; Erdem, H; Haas, DW; Leger, P; Leonard, M; Nwogu, JN; Olson, L; Richardson, DM; Turner, M	1
Alvarellos, M; Brummel, SS; Caudle, KE; Court, MH; Gammal, RS; Gaur, AH; Guillemette, C; Haas, DW; Haidar, CE; Iwuchukwu, OF; Klein, TE; Lennox, JL; Ratain, MJ; Schackman, BR; Whirl-Carrillo, M	1
Baker, P; Bradbeer, C; George, M; Ngwenya, S	1
Bissio, E; Lopardo, GD	1
Collier, AC; Daar, ES; Fischl, MA; Haas, DW; Mollan, K; Morse, GD; Ribaudo, HJ; Sax, PE; Tierney, C	1
Ehmer, U; Lankisch, TO; Manns, MP; Strassburg, CP	1

Reviews

2 review(s) available for atazanavir sulfate and Jaundice

Article	Year
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing. Clinical pharmacology and therapeutics, 2016, Volume: 99, Issue:4 Topics: Atazanavir Sulfate; Genetic Predisposition to Disease; Genotype; Glucuronosyltransferase; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Jaundice; Liver; Pharmacogenetics; Phenotype; Risk Assessment; Risk Factors	2016
Family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability. Archives of toxicology, 2008, Volume: 82, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Atazanavir Sulfate; Bilirubin; Camptothecin; Genetic Variation; Gilbert Disease; Glucuronosyltransferase; HIV Protease Inhibitors; Humans; Irinotecan; Isoenzymes; Jaundice; Neoplasms; Oligopeptides; Pharmacogenetics; Pyridines; Risk Factors; Terminology as Topic	2008

Article

Year

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.

Clinical pharmacology and therapeutics, 2016, Volume: 99, Issue:4

Topics: Atazanavir Sulfate; Genetic Predisposition to Disease; Genotype; Glucuronosyltransferase; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Jaundice; Liver; Pharmacogenetics; Phenotype; Risk Assessment; Risk Factors

2016

Family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability.

Archives of toxicology, 2008, Volume: 82, Issue:7

Topics: Antineoplastic Agents, Phytogenic; Atazanavir Sulfate; Bilirubin; Camptothecin; Genetic Variation; Gilbert Disease; Glucuronosyltransferase; HIV Protease Inhibitors; Humans; Irinotecan; Isoenzymes; Jaundice; Neoplasms; Oligopeptides; Pharmacogenetics; Pyridines; Risk Factors; Terminology as Topic

2008

Trials

1 trial(s) available for atazanavir sulfate and Jaundice

Article	Year
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202. The Journal of infectious diseases, 2013, Feb-01, Volume: 207, Issue:3 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Bilirubin; Genetic Variation; Genotype; Glucuronosyltransferase; HIV Infections; HIV-1; Humans; Jaundice; Oligopeptides; Pyridines; Ritonavir	2013

Article

Year

Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.

The Journal of infectious diseases, 2013, Feb-01, Volume: 207, Issue:3

Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Bilirubin; Genetic Variation; Genotype; Glucuronosyltransferase; HIV Infections; HIV-1; Humans; Jaundice; Oligopeptides; Pyridines; Ritonavir

2013

Other Studies

5 other study(ies) available for atazanavir sulfate and Jaundice

Article	Year
Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation. Pharmacogenetics and genomics, 2018, Volume: 28, Issue:1 Topics: Adult; Atazanavir Sulfate; Bilirubin; Black or African American; Female; Genetic Association Studies; Genotype; Glucuronosyltransferase; Hispanic or Latino; HIV Infections; HIV Protease Inhibitors; Humans; Jaundice; Male; Middle Aged; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; White People	2018
Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes. Prescrire international, 2009, Volume: 18, Issue:101 Topics: Anti-HIV Agents; Anti-Retroviral Agents; Atazanavir Sulfate; Drug Approval; Drug Therapy, Combination; Europe; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Jaundice; Lopinavir; Oligopeptides; Pyridines; Pyrimidinones; Randomized Controlled Trials as Topic; Ritonavir; Torsades de Pointes; Viral Load	2009
Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary. International journal of STD & AIDS, 2012, Volume: 23, Issue:10 Topics: Anti-HIV Agents; Atazanavir Sulfate; Delivery of Health Care; Female; Germany; HIV Infections; Humans; Hyperbilirubinemia; Jaundice; Oligopeptides; Pharmacopoeias as Topic; Practice Guidelines as Topic; Pyridines; Referral and Consultation; United Kingdom	2012
Incidence of hyperbilirubinemia and jaundice due to atazanavir in a cohort of Hispanic patients. AIDS research and human retroviruses, 2013, Volume: 29, Issue:3 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Female; Hispanic or Latino; HIV Infections; Humans; Hyperbilirubinemia; Incidence; Jaundice; Male; Middle Aged; Oligopeptides; Pyridines	2013
Atazanavir (Reyataz) and emtricitabine (Emtriva) for HIV infection. The Medical letter on drugs and therapeutics, 2003, Nov-10, Volume: 45, Issue:1169 Topics: Anti-Retroviral Agents; Atazanavir Sulfate; Deoxycytidine; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Emtricitabine; HIV Infections; HIV-1; Humans; Jaundice; Oligopeptides; Pyridines; Randomized Controlled Trials as Topic	2003